Infusion Pumps and Devices: Technologies and Global Markets
Report Highlights
The global market for infusion pumps and devices reached $18.5 billion in 2015. The market should reach $19.6 billion in 2016 and nearly $25.8 billion by 2021, growing at a compound annual growth rate (CAGR) of 5.6% from 2016 to 2021.
Report Includes
- An overview of the global market for infusion pumps used for continuous or intermittent administration of medications (including antibiotics), nutrients, and analgesics.
- Analyses of global market trends with data from 2014 and 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Coverage of medical, scientific, technological, social, and economic issues associated with this market.
- Evaluation of the current market and variable factors of each category of diagnostic or therapeutic product.
- Discussion of changes to the regulatory environment and delivery infrastructure due to healthcare reform in the U.S. and other countries, and the rapid changes in product offerings following a series of high-profile product recalls.
- Examination of the transition to "smart pump" technology and the complex systems that complement and compete with infusion pumps as modes of treatment.
- Profiles of major players in the industry.
SCOPE OF THE STUDY
Infusion pumps and devices range from very simple mechanical devices to sophisticated microprocessor-controlled pumps. This report focuses on the global market of infusion devices and applications as medical equipment. This report focuses on the global market of infusion pumps and devices, providing an updated review including basic design and its applications in various arenas of biomedical and healthcare sectors. The report covers the total market, which includes two broad categories: general infusion pumps and devices, and specialty infusion pumps and devices. General pumps and devices are categorized into large volume infusion pumps, ambulatory and disposable pumps, syringe infusion and chemotherapy pumps. Specialty pumps are categorized as enteral, patient-controlled analgesics (PCA), insulin pumps and implantable pumps. The report also covers the market for infusion devices by the end user, with emphasis on the usage of infusion pumps and devices in therapeutic categories and various disease sectors. The end users for infusion devices considered in the report are diabetes, anesthesia and analgesia, oncology and blood disorders, nutrition, other applications such as treatment of diseases like congestive heart failure, Parkinson’s disease, hemophilia and immune deficiencies.
The scope of the study is global. BCC Research analyzed each market and its application, regulatory environment, new products and advancements, market projections and market shares. The geographical regions covered in the report are North America, Europe and emerging markets. The emerging market covers countries such as India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand, Canada, etc.
Also included in the report are relevant patent analysis and comprehensive profiles of companies that lead the infusion devices industry. The key market players include Animas Corp., Baxter International, B. Braun Melsungen AG, Fresenius Kabi AG, I-Flow Corp., Hospira Inc., Insulet Corp., Medtronic, Moog Inc. and Smiths Medical.
Analyst Credentials
Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.
Report Highlights
The global revenue for the infusion pumps and devices market reached $17.8 billion in 2012. This market is expected to grow to $18.7 billion in 2013 and then to $23.7 billion by 2018 at a compound annual growth (CAGR) of 4.8% from 2013-2018.
Report Includes
- An overview of the global market for infusion pumps used for continuous or intermittent administration of medications (including antibiotics), nutrients, and analgesics
- Analyses of global market trends, with data from 2011 and 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
- Coverage of medical, scientific, technological, social, and economic issues associated with this market
- Evaluation of the current market and variable factors of each category of diagnostic or therapeutic product
- Discussion of changes to the regulatory environment and delivery infrastructure due to healthcare reform in the U.S. and other countries, and the rapid changes in product offerings following a series of high-profile product recalls
- Examination of the transition to “smart pump” technology and the complex systems that complement and compete with infusion pumps as modes of treatment
- Comprehensive company profiles of major players in the industry.
Report Highlights
- Global spending on infusion pumps were $6.4 billion in 2008 which increased to $7 billion in 2009. This is projected to reach $9.6 billion in 2014 at a compound annual growth rate (CAGR) of 6.5%
- Spending alone in USA was nearly $3.3 billion in 2008 which increased to $3.6 billion in 2009. This is projected to reach $4.8 billion in 2014 at a compound annual growth rate (CAGR) of 5.8%
- Spending in Europe was $1.9 billion in 2008, which increased slightly in 2009 to $2 billion. This market is projected to reach approx $2.8 billion in 2014, for a 5-year CAGR of 6.4%.